Clinical Trial Update: Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 dose-escalation study evaluating the safety, pharmacokinetics, and dose-finding of cabazitaxel in combination with gemcitabine in patients with mali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasms

Drugs mentioned

• Gemzar (gemcitabine)
• Jevtana (cabazitaxel)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms, Malignant | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-09-11